CIK 0001447362 · Accelerated filer
CASTLE BIOSCIENCES INC
Sign in to watch- Ticker
- CSTL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770701774
- Phone
- 866-788-9007
- Business address
- 1500 W. PARKWOOD AVE., SUITE 400, FRIENDSWOOD, TX, 77546
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,765,795
- in 18 filings, $4.9M under 10b5-1 plans
Net −$5,765,795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-12 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −948 | $34.15 | $32K | 63,891 |
| 2024-11-12 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −300 | $34.15 | $10K | 6,160 |
| 2024-11-12 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −299 | $34.15 | $10K | 6,151 |
| 2024-11-12 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −299 | $34.15 | $10K | 6,151 |
| 2024-11-12 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −299 | $34.15 | $10K | 6,151 |
| 2024-11-05 | Juvenal Tobin W Chief Commercial Officer | Option exercise 10b5-1 | +3,507 | $3.38 | $12K | 57,685 |
| 2024-11-05 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −3,507 | $35.56 | $125K | 54,178 |
| 2024-11-05 | Juvenal Tobin W Chief Commercial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −3,507 | 16,603 | ||
| 2024-11-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −1,943 | $32.53 | $63K | 89,721 |
| 2024-11-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −995 | $32.53 | $32K | 75,641 |
| 2024-11-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −934 | $32.53 | $30K | 64,853 |
| 2024-11-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −295 | $32.53 | $10K | 6,465 |
| 2024-11-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −294 | $32.53 | $10K | 6,455 |
| 2024-11-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −294 | $32.53 | $10K | 6,455 |
| 2024-11-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −294 | $32.53 | $10K | 6,455 |
| 2024-11-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −29 | $33.16 | $961 | 89,692 |
| 2024-11-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −15 | $33.16 | $497 | 75,626 |
| 2024-11-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −14 | $33.16 | $464 | 64,839 |
| 2024-11-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −5 | $33.16 | $166 | 6,460 |
| 2024-11-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −5 | $33.16 | $166 | 6,450 |
Page 32 of 45 · 897 trades